tv Squawk Box CNBC January 30, 2015 6:00am-9:01am EST
>> live from new york where business never sleeps this is squawk box. >> good morning, everybody. welcome to squawk box here on cnbc. final preparations are underway in phoenix for this sunday's big super bowl. and if you were under the impression that this is all about football well think again. this is the food. there's the ad watching and now there are some crazy bets that are being made. among the wagers that you can make, how about what color hoodie will bill belichick wear? how many times will tom brady's wife appear on screen or will russell wilson throw for more yards than the total number of cents gas prices will cost on monday morning. we'll have more of the off the gridiron games in a few minutes. >> any bets on whether they're
deflated balls? >> that would be a bad bet. >> let's get you through some of the big stories they're watching this morning. the first read on fourth quarter gdp at 8:30 eastern time. forecasters say the economy likely grew at an annual pace of 3.2%. and then coming up on the earnings front we'll be looking for results from chevron, eli lily and mastercard all before the opening bell and in global news russia central bank made cutting rates unexpectedly. the rouble extending losses after that news. he'll join us from moscow in a couple of minutes. >> number of stocks we'll be watching today. we mentioned google at the top. declining online ad prices. also unfavorable foreign exchange rates. google has been a great stock though. we'll keep an eye on it throughout the session.
amazon's earnings were much better than expected on strong holiday sales. the company gets about a third of its revenue from october to december and it's current quarter guidance falls short of consensus but we're going to look through all of these things and decide which way to play the stock with an analyst that covers google and amazon in a minute. visa topped wall street forecasts. the company pointing to strong holiday season and strengthening job market encouraging people to spend and also afounsed a four for one split of its common stock. shares of deckers, cutting it's full year forecast because of slowing demand of its ugg branned shoes in the u.s. broadcom exceeded expectations. check out the shares of synaptics please. they make display trooifrs for
smartphones. latest results were above expectations expectations. >> you have to divert your eyes if you don't want to see the price. it's right over your shoulder. >> what if someone didn't want to check it out. they're like this guy is bossy. >> they're watching the channel for a reason. >> they may not want to look at it. >> they're smaert. >> if you would like to look at it. here is where it is. i don't want to be pushy. >> i would like to show you a few other stocks. >> a little bit of decorum. >> costco came out with a special cash dividend to $5 a share. take a look at those shares this morning. honda is cutting it's annual profit target. setting aside hundreds of million dollars in cash. valiant is buying prostate cancer vaccine from the drug maker. the price tag almost 300 murder in the second degree but that's what they were already making in revenue.
that was part of the problem with what brought them down. how expensive the drug had been. this is one of the deals. this deal is subject to higher and better bids. the fda approving two six dose hiv pills. they combine inhibitors made by johnson & johnson. a boosting agent is produced by gilead. >> and shake shack is making its public debut. the new york based burger chain's ipo pricing at $2 is a share above the 17 to $19 expected range. the offer valuing that chain that started as a hot dog cart if you remember in madison square park at about 700 $45 million. this makes no sense. they have a couplel dozen stores. >> how many are there?
>> the number is 30. they hope to get to 450. buzz feed has a hilarious map of all the places they could go but i don't know. just seems tough. but you don't want to miss a restaurant tour. danny meyer is the founder but also the ceo of shake shack on squawk on the street later this morning. >> let's check on the markets this morning. we'll take a quick look at where the futures are after a great day yesterday. i guess some of that had to do with claims numbers. i don't know whether good news is bad or bad news is good or what anymore. it looks like the fed is going to remain patient but they're still on track and every time we get a good number if they're going to be patient we have the rest of the world cooling inflationary concerns. you think sooner or later people come around to this being seen as a positive. hopefully the gdp number isn't too far below fourth quarter when we did 5% but they'll get some back. >> the futures were down more than 100 points earlier.
>> yeah? >> yeah. >> do you think it's fair? >> i have no idea. if they price it and sold the stock and it's going to open there then it's fair. it's just by deaf situation where the supply and demand with the underwriters and how they work you may be right. a year from now it could be down 40% from where it is but could be up 40%. i don't think we have any idea. i. >> i think you like uber stuff better. this is just food. >> look i'm a big -- we go there all the time. if they can deliver it over the internet it would -- >> print it on a 3-d printer. >> i don't know if you can yet.
>> you can do it. i'm trying to think of an airbnb. if you could get it from the cloud you'd like it. >> it's just too low tech for you. >> that's what i want. >> you want a 3-d. >> 3-d printer. if i could print whatever i wanted at home and then eat it. >> i don't understand the whole concept. especially like printing organs or something. i don't know. >> it's a little above us. >> it is. let's look at europe at this point in morning and see whether we can glean anything from the action there. it's pretty flat. that scares me. 740 points. it's just not that many points in greece but a little bit better. better today. we'll see what happens. let's look at asia. quickly. the asian markets down 1.5% and as far as shanghai goes let's look at oil which yesterday was bottoming at 40 to 45. can't go much lower than where it is according to all of our
guests. 4495 was the close. the ten year it inched up a little in terms of a 173 yesterday. it's back down to 171. a great month for bonds. no one would have thought you could make a lot of money down to 1.7 but you could have. the dollar versus the other currencies, great time to go to europe. getting better and better at 113. that's improved. that was at 112 before and we'll check out gold which got close to 1300. it's back down a little and now back up today though to 1264 but remember we were down at 1200 for awhile. almost got too much. you can see it on the right hand side of that chart. it has been in a mini bull market. >> let's talk about the technology apology juans. google and amazon posting results. google missing the market while amazon posted a blowout quarter.
back with us is collin senior technology analyst at bcg financial and you said yesterday you thought this would be the time for amazon bringing in profits. they came in for profits almost three times what was expected. >> joe asked do profits matter? clearly they do. the market reacted quite positive. we were looking for that north american operating margin segment to rebound and we got it. we got more than what we were looking for. it's still a 5% margin. it's still a very low margin business. their forward guidance is still for a loss to a very small profit. nothing has fundamentally changed. it's still jeff besos constantly investing but they did show the leverage for the model. for the quantity of revenue you have a lot of profit. >> you're saying they did it this quarter just to prove to the street we can turn it if we feel like it? >> hard to say if they intentionally did it or didn't. we talk about the publisher brush up that did depress
margins in the september quarter. we got a nice little rebound. it's important to remember their net income was 214 million. it was actually lower than the prior years december quarter. so the market reaction gained $15 billion. north of 10%. >> yesterday when you were saying you thought this was going to be a great time to be in amazon this morning it's up $345. do you still like it at 345? do you still buy it? yes because the momentum is back in the name. seeing these big swings in the stock is something that makes it difficult to own, right? because like i said the thesis and the story really has not changed. they're still going to be investing. we'll see how the march quarter tracks but they could go back to posting losses. >> you said yes but sounded more hesitant. >> had a nice big move right? >> maybe not. so you take the money you gained
and like i said the momentum is in the name. let's see how march quarter tracks. >> let's talk about google because that one did not hit all the metrics that the street was anticipating. >> yeah. i could hear the arrow whistling by my ear. stock was down 5% at one point. now it's back up. this is the reset. if you hold a multinational the impact of the stronger u.s. dollar is really quite material. you know 200 -- >> i never thought of google as being a multinational. i think of companies like a coca-cola, procter & gamble. it surprised me to see foreign exchange being such a big issue there. >> yeah 4% of revenue growth: it doesn't look quite as strong. google is a fantastic core business. there's some maturation that's
happening. we continue to see it in the paid clicks and click pricing that haven't resolved mobile phones as well as desktop search so there's all in our view. stock trades around 17 times for a company that's growing around 17 times. jumped right out of the dpat saying this is a noisey quarter. i had one time expenses that were unusual around 300 million. so it's a lot better than it looks guys. don't get too upset with us. >> that's when the stock turned. >> yeah. i don't think anything will be moving either way. >> do you feel like this is where you look past foreign exchange issues? >> yeah think about how many times a day you use google services. they arguably make some of the world's best software.
i use google services dozens of times a day and they're going to continue to mon tiezitize them. you have to like that they're putting money to find the next big revenues. >> do you think there's any chance they lose access to the iphone? one of the things we heard marissa meyer talking about is her hope that she becomes the search engine on iphone this spring and that deal is up for grabs. >> if i were tim cook and i had eric schmidt on apple's board and google comes out with an android and chases after my core business. >> that's three or four years ago. i hear you right? i would kick them out but for the economic benefits to google whoever wins that deal all the economic benefits will flow to apple. just the amount of revenue they have to pay out. >> it's a mind share. >> so you think there's no number? there's no profit number
attached. >> a little. maybe 80 or 85% of the benefits flow back to apple. apple can't lock google out of their platform. >> thank you for joining us again today. it's good talking to you. >> the big global market story. a surprise interest rate cut. jeff joins us from moscow this morning, jeff. >> yeah hey, good morning to you. well it just shows the russians still know how to spring a surprise occasionally. no one had this pencilled in as a rate cut today. the analyst consensus was there would be no change because inflation still sitting arn 12% and they expected it would top out somewhere around 17 but clearly the russian central bank has decided that enough is
enough enough. the combined pain of falling oil prices and saifrksthis economy wiped $200 billion off of the economy last year. instead of sticking with the inflation line they're going to try to reach for growth. that's why we have seen the 2% cut in interest rates. i spoke to the head of russia's second lanchest bank vtb just before this decision was announced and i asked him where he felt interest rates should be for this economy. >> i am not a supporter of high interest rates. the central bank should bring it down. but if it stays high for too long i think it will create a lot of problem and we expect already negative economic growth, gdp growth. >> the interesting thing is the last couple of days we have seen international companies like gm say they're going to suspend
production here for a few months as a result of a slow down in this market. and they've shutdown a couple of the beer plants. so it's not just the russians who are feeling the pain of sanctions in the falling oil price. you can clearly see international investors taking it on the chin here as well guys. back to you. >> jeff i understand that we always follow the direction not necessarily the level of rates but when you're still talking about 15% interest rates it still seems like that's a high number even though they just gave up 200 basis points off the bat. my other question is this isn't good for the rouble and isn't that a big deal for them as well? >> yeah absolutely. i agree on both those counts. they lifted interest rates 11.5% through 2014. as they fought this rear guard action against the big sell off in the rouble as the oil price declined and then we had the
dramatic two weeks in december. the last time i was here in moscow where they moved 650 basis points overnight to try and stop the outflow. so as far as they're concerned now they think they got some stability back in the russian currency and that's given them a window of opportunity for the rate move. but you're right, real rates when you put in the banker's margin are still going to be somewhere around 17 18 19%. that's not a huge incentive to borrow but because of the sanctions, people here really don't have too many options. capital markets internationally are being closed to them. back to you becky. >> thank you. seems like they may be stuck in the worst of all possible worlds at this point. really high interest rates still. lousy rouble. thank you. this is something that a lot of people didn't see coming but i think you did. >> well i had an interview with
the russian finance minister and you can sewe more about that online and he said we think the volatility has declined in the rouble. we think the interest rates are the wrong number for the current conditions in the economy. now like every other developed government and central bank around the world the russians continue to argue their central bank is independent but when the finance minister is saying we really think interest rates need to come down you can imagine there is a good deal of pressure being placed on the central bank here and you do get the feeling that there's a little more confidence that the rouble found a more natural level given where we have come on oil prices. if you look at the two charts becky oil and the rouble came down through the last 12 months parallel. so if the oil price is bouncing or steady around here there's good reason to believe that the rouble can remain steady as well and that's given them the window
of opportunity. the remarkable thing is that the economists were all looking in the wrong direction. they were focused on inflation. none of them seemed to be looking at the markets to volatility but that's why they're economists and not traders. >> jeff thank you. we'll talk to you again soon. >> okay when we return we're going to talk about the oddest super bowl bets including katy perry. the star of this year's halftime show all happening on nbc. but first here's a look back at this state in history. we're back in a moment. ♪
i've been called a control freak... i like to think of myself as more of a control... enthusiast. mmm, a perfect 177-degrees. and that's why this road warrior rents from national. i can bypass the counter and go straight to my car. and i don't have to talk to any humans, unless i want to. and i don't. and national lets me choose any car in the aisle. control. it's so, what's the word?... sexy. go national. go like a pro. take a deeeeep breath in... and... exhale... aflac! and a gentle wavelike motion... ahhh-ahhhhhh. liberate your spine... ahhh-ahhhhhh...aflac! and reach, toes blossoming... not that great at yoga. yeah, but when i slipped a disk he paid my claim in just four days. ahh! four days? yep. see why speed matters,
when they say your. >> we mean ours. >> all the weekend hopefully. >> it just seems selfish. jen, you know i'm not going to push you around but if you get a chance after giving everyone else their weather forecast could you give us our weather forecast too from the weather channel. >> here's the thing. what's mine is yours, what's yours is mine we are all in this together. >> okay. >> that's true. >> more snow. i'll give you a personal forecast, though it's cold. we have cold cold cold coming. there is a clipper system. it's called carrie and we're seeing the snow mainly in maine. we'll pick up 8 to 12 inches of snow. you saw a few flurries out here today in new york city. especially lower manhattan. the story is the cold behind carrie. you'll see temperatures dropping off sub zero and wall street way down to southern new england. we're going to be in the single
digits probably in town. it will feel like single digits saturday morning. that's going to be the story. this cold air from canada this is about 20 degrees below zero up here. a piece of that is getting down into the northeast for saturday morning. that's story number one. story number two is our rain for super bowl fans out here today and tomorrow in the southwest but this is half of a system that is going to be tracking across the nation. it's a cross country storm. you get the two to combine. the northern system and southern system and by sunday this is a big weather maker. chicago, you have the snow shovels out and snowplows out. on monday it's moving back into the northeast and we're talking about another big weather maker here. inches of snow new york city boston, rain-snow line is going to be an issue and monday is groundhog day so that's the day we find out if there were six more weeks of winter.
>> oh they're not picking him up anymore. >> dropped him on his head. he's dead. >> what does this new ground hog know about forecasting? >> i don't know. but they're not going to pick him up. >> if he tries to pick you up sometime. just run the other way. anyway, thank you. we appreciate it. i do love that movie. we're just days away now from the super bowl. and even if a football isn't your game there's plenty of other things to keep you engaged including crazy bets. for example, what color hoodie will bill belichick wear? katy perry is the star of the halftime show. will she wear her hair up or down? if she wears a whip cream bikini and you bet $100
does have a bikini? what will she sing? long shots 25-1. how about a squawk friend al michaels. >> beattie heart of business. new york city. >> thank you al. >> this is "squawk box." al, are you with us? >> he is hangs out. he just hangs out. >> he likes red ties. >> so did reagan if you remember. i hear -- well, al is a lined a little bit with red tie. >> no with reagan. any way you can bet on that if you'd like. he probably doesn't want that to get out. maybe you want to wager if at some point he mentions the point spread. andrew asked about deflategate earlier. is there a moratorium on talking about it? it's a long shot but if you wage
$100 and you get a $1,500 payout. what time is the actual kickoff? >> around 6:20. >> is that right? >> usually. >> do you know? >> i was going to guess 6:00. >> anybody can help with us? >> i was going to guess 6:00 but i think you're right. >> 6:30. we have been on the west coast a few times. >> you get to watch it early in the day? >> out there, we have been but not this year which is a little bit different. >> you're coming over to my place to a big super bowl party? >> is that in the mail? >> you didn't get the invitation? >> no. you? >> no. i'm going to bed at halftime. i'll just watch the first half. >> really? >> do you know what time -- you know what? i'll watch until 9:00. >> what type of fixings you
going to have? all of them? >> i got a little has batchy so i can make different barbecue things for you guys. >> do you guarantee me you're not putting on nabby at 9:00? >> after what is happening with mary? >> not in the living room. >> don't spoil! don't spoil! >> okay. we got to go. i'm not giving you grief. >> two of the world's best known deal makers. united on "squawk box." find out what they think plunging oil prices could do to mma. as we head to a break take a look at yesterday's s&p 500 winners and losers. ♪
life from the beating heart of business, new york city. this is "squawk box." >> welcome back to "squawk box" this morning. good morning. low oil prices giving mma activity a boost in the energy sector hitting a ten-year high and oil prices hoverings $45 a barrel and we will talk about a lot more. ralph is the ceo and blair is the partner and cofounder of centre view partners. did i call you ever view and
center corps? i think so conflating the two in my head least. where do you think things are? we are now coming up at the end of what seems like a bad month in the markets at least it feels like and does that portend a choppy mma confidence? does that mean we are going to have a tough year? >> i think first of all, we came off a very strong year last year. mma dollar volume was up 47% globally although it was predominantly in larger deals, roughly 70% in those deals came from deals in $5 million. so with we got positive momentum coming into this year. i think generally if we don't get an exogenous event and i wouldn't destroy the volatility in the market right now to be that sort of thing that momentum will continue. >> are ceos looking at this
situation, the oil issues and everything else saying they want to hold and wait or thinking things are great, let's dive? >> for the most part i'm with ralph is. ceos remain confident. mma is off to a pretty good start. 200 billion transactions in january. the big question is you've had three pricing stocks oil, the dollar and the swiss franc. it's basically having ceos saying maybe we ought to wait a little bit until equity values settle out but i don't see it in any way as retardant to -- >> how much do you think your business can be driven by activism this year? both of you are involved or have been on the other side of a nelson peltz situation. you were on pepsi and you're on dupont right now. >> activism is as active as it's ever been. it is $200 billion worth of
buying power before leverage. not a company in the country that is immune to it and we spend a lot of time with it. the question is always making sure and i'm not sure where it is, but making sure the companies are making the short term and long-term decisions. pepsi was performing really well. top shelf return. top economic performance. nelson recognized that and i think it's a -- >> is the right strategy we see it more and more to take the activists and try to bring them under the tent? is that a silencing strategy? what is that? we see it over and over again. nelson peltz a seed of sorts on pepsi. i don't know where you think dupont will ultimately land. >> obviously i'm not going to comment on that but look. i think, first of all, the idea
which may have existed five to ten years ago of an insular board that is a sinacure and filled with pure supporters of the strategy of the chief executive and of the company is a thing of the past. and so as a general matter boards are much more responsive to shareholders, much more responsive to different perspectives and i think anyone whether they are in the legal community or investment banking community, would advise boards to do that and the real question is you don't want to do something that disturbs the ability of a board to freely interact and to develop the best as blair said long term and short-term strategy for shareholder -- >> a bill johnson is a talented board member on pepsi that any board would be happy to have.
the fact is it's a good thing that someone like nelson and someone in a company like pepsi can recognize that as a commonality. >> a piece on "wall street journal" talks about the falling prices for oil the pain is starting to be felt. i wonder what you think this lead to in terms of opportunity. investors have come on the show and said this is an opportunity of a lifetime when you get to the oil patch. >> it's always an opportunity of a lifetime. oil has had this kind of drop six times the past 30 years. so each of those lifetimes, what has happened at least in the mma part of the cycle, the delay for activity is actually been measured in quarters not months and makes sense. you're sitting there as a ceo, the first order of business is to figure out where you stand as a business and what is your strategy, what is your plan to deal with a new environment? that takes time. there is also the reality of
figuring out what is the right valuation, what is the right stock price for any company, and you don't want to as a buyer, be there -- you'd rather be a little late than a little early. >> i would say in the energy sector i completely agree with what blair said that you can have a lot of mma activity when prices are high as we did, and you can have a lot of activity and will when prices are quite a bit lower. it's the interragnum when they are in the unsettled mode that you're going to have a more -- period. >> you don't want to look foolish if you're buying in the middle of the process. >> sure. take time. if you're thinking about energy mma, my bet is 2016 will little more interesting and robust than that. >> you're my consumer goods guru of sorts. >> there you go. >> a couple of things. we have seen coke and mcdonald's struggle. do you think those are fixable
businesses? >> i do. i think, fundamentally -- >> i know you're not a coke guy but a pepsi guy. i would say it's a powerful brand name and it's very hard across any business to hurt a powerful brand name with the right management. in terms of the fixes, not easy. >> different question. you're a valuation guy too. shake shack has a public offering today. does that math make sense to you? a guy that goes into board rooms and tell a guy to buy companies based on certain valuations since this is your space, what do you say? >> more importantly, i'm a big user of the product. >> he's dodging the question. >> listen. i think that there are valuations generally in smaller companies that will have to prove out a lot of growth. shake shack has done a lot of growth. >> that's a great product. look at blair's figure. >> i need to ask you.
a memo. you seen the reporting on this that evercore suggested to samsung to buy becky's favorite company. >> i'm holding on to the keyboard. >> first of all, i'm not going to comment on that other than to say investment bankers bring lots of presentations to lots of clients. sometimes you visit a client and they don't each know what you're going to talk to them about. so leave it at that. >> okay. i have a final political question for both of you because both of you have been historically democratic supporters. your names have been bandied about historically as people who might wind up in washington. what do you think has been the repercussion or impact of what happened to antonio weiss, vis-a-vis elizabeth warren and what that is doing to the party and your standing in it. >> so i'll start. i think that the party remains a
party where there is an ultimate common goal. broad-based growth for as many people as possible that is always what we are about. there are always going to be periods in any party where certain groups are more in favor of certain groups or less in favor, and i think regarding what happened to antonio, he is a quality individual as there is. and i think -- i imagine it's a moment in time and that -- >> is that a moment in time that just last six months or do you feel like the next four or eight years are going to be very different? >> i don't think it will be different. what i believe is individuals who are broad-minded will always be welcome, and by different parts of the party and i think the key is for the party in '16 to have a unified message and the question elizabeth warren
versus whether it's anyone else will be no different than jeb bush versus rand paul. >> broad-based growth for as many people as possible. so i guess if you ask a republican that he'd say, growth for as many of the 1%ers as possible inspect that how you distinguish the party? what if the republicans said -- >> he has been so quiet during this segment. >> what if the republican were to say, broad-based growth for as many people as possible but we actually think the private sector should be providing the growth instead of the government sector. that would be the difference i guess, right? >> we do too. >> there you go. >> how about you, ralph? broad-based growth for as many people like we have seen the past six years for the middle class? >> what i would say is broad-based private sector growth. >> thank you! that's all you needed to say. i would still be over here not saying anything. >> i think to get back to the question andrew asked, i think, first of all, this is not a new phenomenon. since the financial crisis
anyone who has had success in the financial community has, you know in fairness been walking around washington with a target on their front. >> right. >> and their back. >> and back. >> and that is not -- i would argue that is not even just a democratic party phenomenon. it's broad-based phenomenon and i think is continues for some period of time. i would say even though -- i am one of those people i really don't think that is a particularly good thing for this country. >> you look at the problems where they don't have the strong capital markets we have here and one of the reasons that we have distinguished ourselves as an economy here is because of our strong and vibrant capital markets that you two gentlemen are part of. so it's sort of doesn't make a lot of sense that, you know -- >> doesn't. that's why i think it is short term. it has never been a long-term horizon where people who want to serve from different sectors who have the talent to do it are not
at more points than not welcome and i don't think that is going to change i don't. >> i think that the whole warren movement is really almost -- the tea party represented to some people a plus for the democrats. i think elizabeth warren is a huge plus for the republicans. >> i think so. the wings of both parties are -- >> detrimental. >> -- are negative to the party themselves and also to the country as a whole. >> okay. we got to leave it there. the dynamic duo that is ralph and blair. now that we are a all neighbors, pop on back. >> it's really easy. >> ralph, over the years, we have become -- i feel very close to you. i do. in a lot of different ways. you know? >> you know, let's have lunch. >> okay! let's do it! if you call me i would say have your person call my person but neither one of us have people. >> he's got a person. >> he has a person? let's not talk about that. he has percents. the ceo of ad giant bbdo
would you take the call to pretend i have a person? >> i'll e-mail you. >> e-mail me! e-mail andrew he'll forward it to me. >> what is arguably the biggest weekend of the year in the marketing police. plus fred hassan will be here. he is behind a lot of things happening and he is living in the world of private equity and looking for the next big business before the accident. eli lilly out with results this morning. the ceo will join us first on cnbc. ♪
seconds! it's safe to say a lot is riding on every frame. we will talk to a man behind some of the biggest advertisers. the ceo of worldwide right after this. ♪ [ male announcer ] at northrop grumman, we've always been at the forefront of advanced electronics. providing technology to get more detail... ♪ ♪ detect hidden threats... ♪ ♪ see the whole picture... ♪ ♪ process critical information and put it in the hands of our defenders. reaching constantly evolving threats before they reach us. that's the value of performance. northrop grumman.
so if you get a trade idea schwab can help you take it on. tdd# 1-800-345-2550 we're getting a lot of questions tdd# 1-800-345-2550 about organic food stocks. tdd# 1-800-345-2550 [ male announcer ] sharpen your instincts tdd# 1-800-345-2550 with in-depth analysis by schwab experts. tdd# 1-800-345-2550 and if you want to run your idea tdd# 1-800-345-2550 by a schwab trading specialist, tdd# 1-800-345-2550 our expertise is just a tap away. tdd# 1-800-345-2550 what's on your mind lisa? tdd# 1-800-345-2550 i'd like to talk about a trade idea. tdd# 1-800-345-2550 let's hear it. tdd# 1-800-345-2550 [ male announcer ] see how schwab can help tdd# 1-800-345-2550 light a way forward. tdd# 1-800-345-2550 so you can make your move, wherever you are tdd# 1-800-345-2550 and start working on your next big idea. tdd# 1-800-345-2550 ♪ ♪ tdd# 1-800-345-2550 open a schwab account and you could earn tdd# 1-800-345-2550 300 commission-free online trades. tdd# 1-800-345-2550 call 1-877-670-3357. tdd# 1-800-345-2550 or visit schwab.com/trading. tdd# 1-800-345-2550 schwab trading services. tdd# 1-800-345-2550 your go-to for trading know-how. tdd# 1-800-345-2550 ♪ ♪
one of the regional ads running during the super bowl on sunday. >> i like it. >> we're calling it american family insurance. that's aflac. used to be, right? >> is it part of aflac? >> this is the first time they've ever been in the super bowl. >> aflac is the old american family, right? all right then. created by ad giant bbdo the president and ceo is here. andrew robertson is here with us. how many commercials do you have? >> we've got five in and around the game on sunday. >> five in and around the game. but one thing we keep talking about this year is that since it's $4.5 million for 30 seconds which we think is cheap really. very. >> very reasonable rates this year. >> i mean there's a lot of synergy. but so it is cheap.
but they're sort of trying to get at lo of mileage before during and after. >> you can't really think of super bowl as a single spot in the game. you have to treat it as a proper campaign. an event that runs for at least weeks and in some cases months. if you think doritos is going to crash the super bowl it's the tenth year they've done it. that starts in september. last year they got a hundred million years. >> if someone is a director i'm producing and shooting a trailer for a 30-second commercial. that's weird to me. how long is the trailer for the 30-second commercial? >> sometimes they're very short. sometimes they're ten minutes. >> and it works. >> it sure does. >> and you put it on twitter and facebook because this is the world we're in right now. >> well, the world we're in is the world we're always in. it's just better now because
fame sells. fame sells. if lots of people are all thinking about and talking about your brand at the same time, you get a herd effect on sales. and the only way you can get that kind of bang is with an event like the super bowl where 111 million people see your commercial at the same time. and, you know in the weeks running up to it everybody is talking about it. that's how you sell stuff. >> i look at the way you can value a company. if taylor swift has 51 million twitter followers, what would that be worth to someone that wanted to advertise to her followers? i mean she must -- can you value what she -- even without the music what she's worth? >> i guess if she was -- if they were all going to see it at the same time, you could take this -- >> just because you have 51 million followers doesn't mean they're following every tweet you send out. you have a captive audience for the super bowl.
you have to -- >> i go back and see. >> you follow her so it's different. >> i do. i like her. >> andrew there was a lot of talk about the idea that nbc sold its last ad just this week. $4.5 million. that's a record price. last year they sold out a lot earlier for the super bowl ads. is that because they were underpriced last year? is it because $4.5 million is a lot to swallow? >> they did get it. some people hold back thinking they'll be left back with inventory and people will get a great deal in the last two days. but it didn't work that way. the demand was there. >> i mean, that's just phenomenal. it speaks to how important it is. >> how valuable it is. >> what are you most proud of? which commercial should we watch? >> that's like asking me which of my kids i love most. >> travel safe. good see you. . when we come back we'll
starting now, a special "squawk box" summit. we'll dive into modern medicine with ceos from some of the world's biggest health care companies. from the effects of obamacare to reducing drug costs. from the obesity epidemic to consolidation in the health sector. we'll tackle the biggest issues in american health. it's a special hour of "squawk box" and it starts right now. live from new york where business never sleeps, this is "squawk box." >> welcome back to "squawk box" here on cnbc first in business worldwide. i'm andrew ross sorkin along with joe kernen and becky quick. in the headlines at this hour a key economic report is about 90 minutes away with the government's first reading of fourth quarter gdp. looking for a growth rate of
2.8%. also shake shack is to start trading today. above the expecting range which is higher than initial predictions. and russia cutting its key rate this morning. the rate had been decreased to support the falling ruble. but now another surprise this morning. becky? we do have a number of stocks to watch today. google's earnings and revenue missing the mark. amongst some of the drags they cited declining online ad prices also unfavorable foreign exchange rates. the stock was down just a the news came out yesterday, but then the cfo started talking about things and explaining things that made investors feel better. that stock is trading higher this morning. amazon's earnings blowing away estimates on strong holiday sales. they get a third of its revenue from october to december. its current revenue guidance falls short of consensus. and visa topping wall street's
forecast. a strengthening job market encourages people to spend. visa also announcing a split of its common stock class "a" shares. -- what? visa, yeah. it is. >> so that's helping the dow? it's up $7. all right. >> shares of outdoor footwear deckers gets crushed this morning. cutting its forecast talking about slow demand for its ugg branded shoes in the united states. president obama -- what a good day. president obama's invited the heads of research at several drug makers to the white house this morning to discuss investments, plan to improve health and treat disease. meg tirrell joins us from washington with more. probably has something to do with the thing he said in the state of the union address which now's the time i think everybody would agree with that. because we're almost ready. we're right on the cusp i think. >> absolutely. that's what a lot of people think. we reported earlier this week that several drug makers had
received invitations to the white house today. it is that precision medicine initiative that president obama mentioned in the state of the union address. we now have some details. he'll allocating $215 million in his budget proposal on monday to this project. the funding is going to go to nih, the national cancer institute, fda, and other places. there will be a focus on cancer. and also a push to compile a national data base of more than a million americans and all of their health information. and that will of course include genomic sequencing. but also include things like lifestyle, things from their medical records, use of personal health devices and all sorts of things. it's a comprehensive project but starting with cancer. it's not just sequencing but illumina is among the companies invited to the white house will be at that event today. it starts later this morning. other include vertex, regeneron.
back to you guys. >> all right, meg. thank you very much. in fact, we are very lucky today to have a very special guest joining us this morning to talk more about modern medicine. our guest host is fred hassan. he's partner at warburg pinkus. and fred you hear what meg's talking about. you heard what the president has indicated. it sounds fantastic but it harkens back to 1971. where have we come over those four decades? what can we expect this time around? >> well it's always more complex than the physical sciences. there's so much that still needs to be unravelled. but we've made huge progress. as we heard earlier, this is the time when we really need to get going. the one big event that occurred and i'm so glad that illumina is there. the one big thing that happened
in 2014 is the cost to sequence a genome dropped. that's a massive advance compared to the fact it was millions of dollars only five years ago. that big disruption is going to now enable thousands of whole genomes to get sequenced so you can see the variance and try to link that back to disease. i'm really glad this thing is happening. i wish it had happened a little earlier, but this is the right time absolutely. >> you really think that we're on the cusp of being able to turn the corner and take all this promise that we've talked about for decades and really put it into action? >> well never before has information technology and molecular biology converged the way it is converging right now. just like information technology transformed the financial industry in the '80s and '90s. now information technology combined with molecular biology is really going to transform the health care industry. and it's coming at a very good time. we're dealing right now this is
the big frontier for everybody. what's better than health and wellness? everybody wants to make advances. we are advancing health and wellness, a year and a half every ten years. it's really starting to get better. >> it's almost like metadata. it's kind of daunting and mind boggling. i've wanted it to go faster too. but now we can do the genome for less than a thousand dollars. how much of that is background noise? and then you take a -- so how many total base pairs in a human genome? do you know off hand? >> 300 -- i have no idea. >> base pick. something like that. a base pair. like three. so -- >> yeah those three, yeah right. >> three out of a trillion can cause a disease. you can't look at it as a human and discern what's happening. this is why it has to emerge with i.t. that's where it's finally being,
you know where the promise is we're able to start to do that. >> i think the real problem with this cancer area is it's a very -- it changes all the time. and to chase those mutations is really a problem. and i'm not sure this is going to be that easy a journey. i think it's fantastic that now 5% of lung cancers can be done with very precise medicine. it's fantastic. but a lot of the cancers are very hard to follow. they kind of go in different directions. >> it would be nice instead of understanding when there's something wrong, we still need a lot of work to understand just how everything works in terms of genetics and coding and metabolism and designing. it combines them all, developmental biology. then you think of neurobiology. we haven't even skra ched the surface of that. >> that's the next thing beyond cancer. alzheimer's and parkinson's and als. >> it is daunting and we get frustrated.
i'll tell you what's frustrating about big pharma and maybe less about biotech. sometimes it seems like they squander their research money and their opportunities on extending patent protection or on marketing or getting doctors to prescribe their drug versus someone else's. most of the big discoveries have been biotech. was the last big pharma statins and then add ons to statins. when was the last time a pharma company came up with a ground breaking drug? >> it's a very good question but the reality is there's an ecosystem that you got about 3,000 small shops then in the middle and then the big pharmas to put in the big bucks. right now merck has a fantastic product for immunooncology. i know the lab in cambridge where it came out from but it took somebody with a balance sheet of merck to be able to make the big bets. they're working on ten different cancers now. they're going to take the same
platforms and try it on ten different cancers. that's where you need the big pharma. >> which institute? >> this is to m.i.t. -- this was a small shop right next to m.i.t. and part of a scientist whose name i don't know. but it was part of an asset sharing that merck got. >> so something that seems to be present over ten different types of cancers. that would be -- >> well, this platform works in melanoma. now they're going to validate that in lung cancer. so when you get something like this, you don't know where the limits are. and that's where you need the big bucks. and you have to be somebody with that kind of balance sheet to be able to do that. >> it's interesting. >> fred fortunately is going to be with us for the rest of the show. we have time to talk about the exciting prospects coming up. stay with us. coming up this special hour of "squawk box" modern medicine
welcome back to "squawk box," everyone. we've been watching the futures this morning. things got off to a rocky start with the dow futures down by more than a hundred points. they've halved the losses. down 49 points. s&p futures off 10.5 points. and the nasdaq down by 2 points. of course this comes after a few rough sessions. there was a rebound after the two days that we'd seen earlier in the week with steep losses. we'll continue to monitor it and see where we get towards the opening bell. let's talk about stocks to watch. a mixed quarter for xerox. revenue a little bit short. the company is raising its quarterly dividend. the stock is down by about 4% this morning. earnings for newell rubbermaid beating the street by a penny. that stock's down slightly as well. down by about 23 cents. check out tyco. the company seeing a bigger from
foreign exchange than previously forecast. that's a story we've heard again and again this week. that stock up by just over 1%. >> we're going to hear it again. i imagine eli lilly posted results. beat estimates by 2 cents earning 75 cents a share. revenue, however, was below last year and slightly below forecast. but this is a story we've talked about with this next gentleman again and again because ceos have to deal with patent expiration. joining us now to talk through the numbers first on cnbc, john likt lickliter. john, all coming at a time when you're dealing with, you know trying to manage through patent expirations with revenue sometimes going down year every year. i think for 2014 it was 15%
below 2013. >> it's been a roller coaster, ride. you know we lost our u.s. patent on zyprexa. and we lost our cancer drug, our bone drug, and then our neuroscience product. both coming off patent essentially last year. it's been up and down as you know when you lose a patent in this business, the generic entry comes very quickly. you essentially lose all that revenue overnight. we saw this coming. we've been investing in rnd. we've been replenishing our pipeline. last year four approvals from the fda. so we're launching new products and we hope this year to begin a new era of growth. >> we hear from across the board even from companies like google and microsoft, tech companies. then the multinationals with the exchange at 4-x. how much has 4-x impacted eli
lilly? >> you can expect it did hit our top line in a significant way. we revised our guidance for 2015. the line item guidance we did not change our overall earnings guidance for 2015. that remains at $3.10 to $3.20 on a non-gap basis. the reason is even though our revenues are coming down from those sales in countries that have weakened currencies versus the dollar we actually gain a benefit from the cost of our inventories that sit outside the united states. so our gross maherrgin increases. that tends to balance things out. we did not change our earnings guidance this year but it certainly is hitting our top line. >> hi john. this is fred. >> hi fred. >> we are rooting for you because you're a big believer in rnd. you're a very courageous ceo. what are the hopes for that alzheimer's drug that's in
lilly's pipeline? >> well when you look at the field, fred we've been doing research in alzheimer's now for 26 years, believe it or not. i feel like we're wheel of fortune where you turn the pieces over and eventually you spell something out. i feel like we've got vanna there turning the pieces over and i think we're starting to make sense of this beta amaloy pathway. other companies in the mix with therapies. including antibodies we're in the lead. in our second phase three clinical trial. we partnered as you saw last year with astrazeneca. that's in phase two studies right now. then we have some diagnostic agents and some other potential developments. we're very committed to this area. it's risky. we really don't have today a medicine that provides a real therapeutic benefit for people with alzheimer's and we all know
we desperately need it. >> are we at a point -- or fred maybe you know. are we at a point where we know the buildup of this beta amalloy, is that what causes the symptoms of alzheimer's or is the underlying cause results in the beta amyloid and you end up with it and it has nothing to do with the underlying pathology of the disease? >> joe, at this stage i think what we know is that this beta amyloid tends to accumulate to cluster in the brains of people who later then demonstrate symptoms of the disease. and then develop the disease. there's another protein called tou which coming after the am boid aloid. >> the roche product crashed and burned with the same concept. so is your concept different? >> well there are various types of these antibodice.
some of the antibodies attach to the amyloid. it's a smaller protein. other antibodies attach to the aggregated or clumped together beta amyloid. it makes a big difference how you attach to the beta amyloid and whether that effectively removes it or whether it causes certain side effects. >> yeah. i guess if it just -- does yours work on the peptide? >> yes. actually is specific for the free -- what we call the free beta amyloid. yeah. >> you don't want to add to the clumps. it would be nice to prevent the clumps from forming if that's what's causing the disease itself. >> yeah. so really the big risk that john's company is taking is they're trying to prove the molecule works but also that the cascade is the problem. i think that's the -- >> that's right, fred. i think if you work in
alzheimer's right now, you're trying to validate the pathway and to prove you have a medicine medicine. that's right. >> next time you're on, john we'll talk about pricing it. it's hard to understand how to -- just how we should approach this. you look at the global model, that's not the way to go i think. you need patent protection. you need orphan drugs so that companies put the money out. you got to recoup your investment, but maybe medicare ought to get a better deal. i don't know. therest so much cost containment, we're not sure how to do the pricing at this point. we're all sort of trying to find our way. >> i think for hard to treat diseases, the cms should do something to incentivize people. if people are not sure that they'll get reimbursed on the other end, then it's going to be tough. and for alzheimer's, i think so. >> then on the other side they don't care what the drug does if it's a certain price, it's a knee jerk reaction. that's too much. >> alzheimer's is really expensive though. if you could find a way to cure it -- >> john lechleiter, thank you.
when we return a friend of "squawk" is helping get to harvard. but first the most clicked on symbols on cnbc.com. we're back in a moment. take a deeeeep breath in... and... exhale... aflac! and a gentle wavelike motion... ahhh-ahhhhhh. liberate your spine... ahhh-ahhhhhh...aflac! and reach, toes blossoming... not that great at yoga. yeah, but when i slipped a disk he paid my claim in just four days. ahh! four days? yep. see why speed matters, at aflac.com.
the 4:51 is leaving at 4:51. ♪ they cut the power. it'll fix itself. power's back on. quick thinking traffic lights and self correcting power grids make the world predictable. thrillingly predictable. you just got a big bump in miles. so this is a great opportunity for an upgrade. sound good? great. because you're not you you're a whole airline... and it's not a ticket you're upgrading it's your entire operations, from domestic to international... which means you need help from a whole team of advisors. from workforce strategies to tech solutions and a thousand other things. so you call pwc. the right people to get the extraordinary done. ♪ ♪
i don't know if i would have gotten that answer correct. we're back. chipotle is raising its bet on pizza. expanding to kansas city. this is now its first move outside of colorado. chipotle also owns chop house southeast asian kitchens and they have that in d.c. >> apparently this is called pizza local. >> and you can customize the pizza. >> and it's working in colorado this year. >> is there a connection?
>> i don't know. >> okay. how close is your nearest starbucks? good question. it might be more important than your morning caffeine fix. home values rise when a starbucks hits the neighborhood. appreciated 96% between 1997 and 2014. and they've made the correlation. in new york city you can't go more than two blocks. do we have a starbucks? yeah, we do just around the block. >> yeah. they're everywhere. >> you can't go anywhere. >> no. >> we should tell you one of our favorite humans of new york is helping little humans get to college. he started a campaign to raise $100,000 to try to send middle school students to visit harvard. in five days nearly 37,000 people went online and donated over a million dollars to this cause. that's enough to send the incoming sixth graders of the academy on visits for 25 years.
also enough to launch a scholarship. last week stanton sent out a photograph of an eighth grader who was fantastic. if you've been following in different news. helped fulfill her dream to expose students to higher education. brownsville has the highest crime rate in new york city. the campaign ends on february 5th. coming up more of our special hour on modern medicine. up next the chairman and ceo of celgene will talk cancer treatment and many many things. stay tuned. we'll be right back. opportunities aren't always obvious. sometimes they just drop in. cme group can help you navigate risks and capture opportunities. we enable you to reach global markets and drive forward with broader possibilities.
jay z is taking on spotify. bought swedish company for $56 million. they own spotify rival whim which is popular in scandinavian countries. and eli lilly out with earnings this morning. the health care giant beat estimates by 2 cents with adjusted quarterly profits. revenue was slightly below the street's forecast. ceo john lechleiter told us it has an impact on the top line but they are not adjusting earnings guidance for the year. dartmouth college attempting to curb dangerous behavior among students. they are banning hard liquor on campus. forbidding pledging at fraternities and sororities. and they must take a four year sexual violence prechbs program. that's a big move far school like dartmouth. >> it is.
>> fraternity culture. it's a thing. i was part of a fraternity. maybe it's a generational thing. in universities across the country where it disappears. >> but no hard liquor on campus. so they will be checking? it sounds a little bit like prohibition almost. it's going to be difficult. >> what do you do off campus? so many live off campus. >> it just moves everything off campus. >> right. >> at college i learned that beer was a much better -- i mean by the time you drink enough beer you can barely move. you can, but it's much more dangerous. >> when i was at cornell, by the end of the time i was there they had people that were authorized sort of like bartenders who would come to if a fraternity had a party, they would id you
and put a bracelet on you. it was a whole thing. this is another degree. >> when i was there it was animal house in boulder. biotech stocks have been doing really well. maybe none beentter than celgene. almost a $96 billion market cap. beaten for the past five years. celgene has been one of the standouts. up more than 50% over the past years more than 300% over the past five years. chairman and ceo of celgene is with us. very pleased to have robert hugin on. i can't believe we've never had you on before. i drive by celgene's headquarters all the time. it's right near some great golf courses that are out in the area. >> yes. >> anyway welcome. and for years i've watched celgene go to $96 billion largely on multiple mylnoma.
something that almost cures patients. >> you think about the changes of patients today from just 10 12 years ago, it was a death sentence. now we're talking about people many, many large majority of the patients dying of other things in the meantime. it's just dramatic change. it's producing breakthrough therapies. we're fortunate. we used that initial success to broaden our pipeline. and now we've got a great exciting future. >> you've done some other interesting things. off great drug for cancer. but there's different ways of delivering it. and you found a better way to deliver it which could be a big thing. it's called -- >> abraxane. it's been just exciting. it allows us to build one of the most robust pipelines in the industry on myeloma.
>> this is fred hassan. congratulations. because you really are now big pharma even though you're called a biotech. you're larger in size in market cap than many of the old pharmas. the old big pharmas. what is the secret to your success? is it the selection of the portfolio? is it the culture? or is it just pure luck which is also important in pharma? >> i think it's a lot of different factors that lead to success. but good people matter. people have to make the judgments of where to invest your money, what decisions to make scientifically and medically, but also i think you have to be forward looking and embrace change. this is a world where the pace of change is accelerating. we think about our company the last five or six years. we have totally changed the rnd paradigm. the relationships of collaborative partnering there is what we think we have the right technology.
and sort of just keeping ourselves. we look to find other people that share our vision in the areas that we think would make disruptive breakthroughs and partner with them embrace that. and so i think it's also the culture of seeking really disruptive technologies. don't be afraid of the future. embrace it and go for it and play to make that big change. >> people are excited about the crohn's disease drug. it's early. just entering phase one. >> entering phase three. yeah. it's a big -- it is -- if the results in phase three are anywhere near like the phase two results, the treatment of crohn's will be dramatically changed. >> what's the name of this one? >> it's ged-301. it doesn't have a branded name yet. but it's just dramatic. >> it's autoimmune. >> yeah. and people don't realize how
disabling it it is. >> how many does it affect? >> a million people in the developed world. >> it's a horrible disease. in terms of the way you research this, you can't really do a trial. >> yeah. i think we will have the ability to do placebo trials. the disease waxes and wanes. we're going to do a 52-week trial. we're going to have good induction. but we're going to treat right through. the interesting thing about this product is we don't know how long it works for because in initial studies, patients stayed in a high level of remission far long period of time. it will really change the concept of remission and maintenance. this may be the one treatment that takes care of people for a long time. and the phone calls and the e-mails we get about teenagers that suffer from this it's really a life changing disease. >> i want to ask you about express scripts.
they want to get into the cancer business or -- we don't know what they're going to do exactly. but we saw what they did in december in the hepatitis c world to gilead. what does that mean for you? are people angling already? what's going on? >> you know i think this is a world where everything should be value-based. and there's not any revolution or revelation to people today. it's always -- unless 10 15 years it's been that way all around the world. the u.s. is no different. it is incumbent upon us to discover and develop and commercialize breakthrough products that really make a difference in patients' lives. and you have to be able to justify the value of your product. we have to then ensure there's a system that allows access to patients to breakthrough therapies. we can't let the system stop that from happening. >> how do you feel about a drug company doing that? >> i think doctors should make decisions best for patients. but the system also has to provide the incentives to make
sure we have a fair way of providing the cost reimbursement for people. i think we have to be careful for this whole discussion. we have to do its on a fact basis. the percentage of costs from pharmaceuticals and health care it's not really risen. we're talking 9% 10% of pharmaceuticals. even the congressional budget recognizes when you have increasing use of pharmaceuticals, other medical services under medicare and medicaid actually decline. we have to be careful that we don't throw the baby out with the bath water. we have to invest where we take risks. the revolution that you all talked about earlier in bringing together information technology to revolutionalize is accelerating. we're just the beginning of the great breakthroughs. >> with all the cost containment parameters that we talk about now, you need to be able to work with regulators and with medicare to make sure you get reimbursed. i mean, i'm not saying you need
lobbyists but you need to be able to tell your story why a drug costs $120,000 a year. it's going to get harder and harder. the knee jerk reaction is this pill costs nothing to make. you need to tell the whole story. >> you more than need to tell the story. in our company you can't be a world clas clinician. you can't be a world class commercial person if you don't understand pharma economics. this is not something you do in a silo. the value proposition has to be in the clinical research in your regulatory process. it is all about access. and you need to do that throughout the process. it's part of the fabric of your company. >> you have to depend on government to do the right thing here and have cooler heads prevailing on how you approach it. not a heavy handed approach. >> i think the important thing is that pharmaceuticals are not growing as a total in cost that
much. they're going in line with inflation over the last five years or so. they're really 10%, 12% of the health care system. more than in other countries overseas. this is a bioscience country. this is the country that should support bioscience. >> and the thing to also keep in mind is we're in a race. aging population increasing cancer risk, alzheimer's we were talking about, diabetes. versus the innovation and pace of revelation, we've got to win that race. because if we don't, we have -- >> even more expensive. >> we're part of that solution. and that's what we're committed to being. >> thank you for finally joining us. hopefully we'll see you again. and if we see you in some other city at some point, maybe you can come on the show too if we happen to be in the same place. thank you. >> thank you. >> great to be with you. thank you very much. when we come back this special modern medicine edition of "squawk box" continues.
welcome back to "squawk box." actavis has done over $100 billion in m&a over the last 12 months alone, yet it has had zero inventions over the past year. just hit an all-time high this week. ceo brent saunders is here. he's on the cover of the february issue of "forbes" magazine there. you like that title there? wall street's drug dealer. he joins us now to talk pharma growth and big medicine. let me ask you about what i just read. the zero inventions part. how are we supposed to think about those two pieces? >> i'm not sure that's truly accurate. i mean we have as a company our legacy companies whether it's been act actavis have discovered
medicines and have launched many. we launched several last year. we're going to launch five or six this year. we just don't do the basic discovery. but innovation is a continuum. we do the clinical work and we get it launched and figure out how to make it and scale it up and do that work is that not innovation? >> the question should be what should be the model? valeant when you were competing with, came on our show and we had discussions after discussions about this idea of now rnd. the rnd should be done effective effectively by start-ups then you should buy them. or you should have larger companies. what's the right answer? >> see, i think you have to be committed to rnd and innovation to be successful long-term in our industry. however, you have to do things that you have a comparable advantage doing. and so for us we didn't have an advantage in discovery. we had plenty of access to early stage molecules from universities, from venture back companies and the like. however, as we're completing the
acquisition of allergan they have discoveries and we're going to keep that. in fact, we're going to have a budget of $1.7 billion this year. >> how much do you think m&a as a strategy for the company? >> it really isn't a strategy for our company. >> it isn't? >> we've been inquisitive. you can't argue with that. >> you're going to be one of the top ten drug companies in the world as a result of all these transactions. >> that is true. but we never planned to do it. in fact allergan was not a part of our strategic plan. it was put into play through a situation. we were opportunistic because we had a relationship and it fit strategically with what we were doing. it wasn't like we were out trying to buy allergan. it was something that was a remarkable opportunity because it was a company that shouldn't have been for sale. it was such a well-run company with such great people and such great products. >> it needs to be also said that
brent did a terrific job turning around bausch & lomb and he got to learn the eye business well. when you know the business you have more confidence. >> i know one of your thoughts is the last ten years the industry's really been operating in turmoil. it's been a very difficult time for any business to be out there. things are changing and shifting. i just wonder how the two of you think that means changes for this industry too. >> yeah. so brent, what i was saying was the last ten years the return on investment on rnd has not been that great. probably below the cost of capital. and also the industry has had to go through a lot of difficulties with pairs and really some big restructuring issues as well. overall sgna is now down quite a bit i think a thousand basis points. and the industry has restructured. but the big controversy is is this a time to invest in rnd because we have all the sciences coming together and the i.t. coming or is this the time to be more watchful and just
opportunistic when things come along? >> no, i think it is a time to invest. however, i think there is turmoil. mainly because there's over-capacity. there was over-capacity in the commercial side of the business. there was over-capacity in the rnd side of the business. and so kind of basic economics. as pressure comes into the system as the customers consolidate consolidate. you're going to need to take the slack capacity out of the market. and so should you have seven or eight drug companies targeting the same molecule and same mek anymore of action or should you have two or three? and that's how you get the drugs. there's a lot of money that's spent unnecessarily because there's so much capacity in the market. >> the counterargument would be if you have five or six products you have a numerous auction. >> andrew wrote a huge piece on the valeant model versus the way you're supposed to be doing it. and i think it was classic andrew because it was about the
social value -- >> oh boy. >> no in a good way. the social value of what a drug company is intended to do. is it intended to do rollups and cut costs and reward shareholders or is it intended to spend a lot of money on research whether you win or not because the public good is served down the road from maybe sometimes not the most profitable ventures? >> yeah i mean look. i have deep respect for valeant. i just don't necessarily agree with that business model. at the end of the day we have to invest in rnd. it's the only way to get sustainable growth and get that shareholder return. and also you have the side benefit of doing good things for the society. >> we've been dancing around one issue around this table. we haven't totally got into pricing. >> sort of. >> where do you both really stand on who should -- i mean we've talked about how medicare -- it's very hard to push your prices down. should there be a mechanism that
allows us to have lower prices in the united states, for example? >> i believe in a free market. if we allow for a free market it will continue to make us want to take greater risks, o go for some of the tougher medical needs. >> that's the issue, though brent. if you can't -- if medicare can't negotiate prices it's not a free market. it's almost crony capitalism. that's the whole point. is that a problem? >> well i think you have to look at how the system actually works. you know when you think of medicare medicare mostly pushes their formularies down to a united health care optimum or what have you. so it's not just crony capitalism. there's a lot of intermediaries that play in it. >> a lot of drug companies signed onto obamacare because they knew this was going to be the outcome that they wouldn't be subject to being negotiated down by medicare. >> we feel the pressure all the time. we have a medicare part d drug.
we feel a lot of pricing pressure. and we have to negotiate with the health plans. >> the question i'd like to ask different pharma ceos. your margin in the u.s. relative to elsewhere is broadly speaking what? what's the difference? >> it's kbrt. >> i know. i've never heard anybody give you an answer. >> nobody has. is it 10% higher? 40% higher? >> we don't do it that way. >> but you know the answer. >> of course we know the answer. >> but you don't want to answer. >> we'd have to follow the rules. the end of the day it is better here. but that's why all the innovation is here. that's why the science jobs are here. >> can you tell us what the margin is? >> margins are higher in the u.s. because the innovative drugs get paid for. but if you look at a market basket of products versus canada, let's say, it's not a lot different because generics are a lot more expensive in
canada. >> the big picture might not be so simple. >> the innovation is still what really matters here. because american patients get access to innovation much faster than anywhere else in the world. >> okay. brent, thank you. >> write down january 30th when i used one of your columns and cited it to ask a question. >> it's amazing. >> january 30th 2015. how many years have you been on the show? >> progress. >> i saw you get a little teary. >> i got excited. coming up the animal orchestra is back for one day. they're making super bowl picks. the video you can't afford to miss. i don't know if that's true. anyway, that's next. but to get from the old way to the new you'll need the right it infrastructure. from a partner who knows how to make your enterprise more agile, borderless and secure. hp helps business move
crocodile is making his prediction today. zoo officials decorated two raw chickens with the colors and logos of the seattle seahawks which is kind of a chicken, that hawk is. and the new england patriots. salty leapt out of the water and grabbed the seahawks chicken. in iowa rooty the rooster picked the seahawks. in florida a pair of man tees split. one picking the patriots the other with the seahawks. and in memphis, the panda is taking new england. as for the "squawk box" animal orchestra, they are staying neutral in the super bowl after the miami dolphins failed to make the playoffs this year. that's their favorite team. >> i was thinking they like it because he's an animal. dolphins. he could play in the orchestra if he wanted to.
>> when we return a -- i was going to do a segue, but it's not a good one. jeff bewkes is going to talk to us about consolidation in the media sector. "squawk box" returns in a moment. opportunities aren't always obvious. sometimes they just drop in. cme group can help you navigate risks and capture opportunities. we enable you to reach global markets and drive forward with broader possibilities. cme group: how the world advances.
barbara just bought a bike. she wrote a tweet about it. you can't learn much from that. but take data from millions of tweets combine that with your company's supply chain and sales data. apply ibm analytics and expertise, and all of a sudden, you can learn which bikes to build what to make them from, where to sell them. because barbara and the world just told you how to build a better bike. there's a new way to work and it's made with ibm.
traditional media pivoting to survive in a digital world. >> we got a great name. we've got a great team. we got a great logo. and we've got a great name. now we just need an idea. let's pivot. let's pivot. >> time warner chairman and ceo jeff bewkes talks cable unbundling and why content is still king. data that could move the market. it's the first read on gdp if the fourth quarter hits the tape as 8:30 a.m. eastern. we will bring you the number and the instant reaction. plus the craziest super bowl bets in vegas from marshawn lynch's fines to the color of bill belichick's hoodie. we're going to break down the odds as the third hour of "squawk box" begins right now. live from the most powerful city in the world, new york, this is "squawk box."
>> welcome back to "squawk box," everybody. this is cnbc first in business worldwide. i'm becky quick along with joe kernen and andrew ross sorkin. in our headlines this morning, shake shack is making its public debut. the burger chain's ipo pricing at $21 a share. the offer values. don't miss the ceo of shake shack. they'll be joining "squawk on the street" later this morning. the country dropping its key interest rate to 15%. that's down from 17% for rate cuts to stimulate growth in the sanctions hit economy. also listen to this. measles was declared eliminated in 2000. but the disease is making a comeback. bad news. the centers for disease control issuing a warning last night for americans to get vaccinated. the cdc said 2014 saw the
highest number of measle cases in two decades. it can spread among unvaccinated children. the disease can cause complications like blindness, ear infection, and pneumonia. >> fred hassan is with us. there are 84 confirmed cases of measles just in january in the united states. this is coming after an outbreak at disneyland. or people that got infected there and took it with them. i think there are thousands of people who are probably exposed at this point. what's going on? >> this is ridiculous. i mean this is a 200-year-old battle. we've got to get over this. i think we've got to rely on science. and i really do believe that the cdc and the fda need to come out front and explain the facts. the benefits far, far, far outweigh the risks. all this nonsense about different side effects thus preventing people from getting vaccinated, that's a terrible disservice. >> i think the thing that concerns me the most about it is
if you choose not to vaccinate yourself not to vaccinate your children. you are putting not only your family at risk but others at risk. measles is a disease contagious days before you show up with a rash. you expose all the people you come into contact with. and there are people who can't get vaccinations. children below eight weeks old, if you are someone who has a weakened immune system. you're not at a position you can get the vaccination. >> and if you are pregnant that's a very serious issue at that stage. and i really think we as a society should sometimes discuss freedom of choice. let's look at a place like singapore, it's mandatory. you are not only responsible to yourself, you are responsible to others around you. we should have that discussion here in this country as well. >> if there wasn't this move away from vaccines do you think measles would be back? it probably wouldn't have gotten a toe hold. >> wouldn't have had a chance. even if you're at the 95% level,
it just will not come back. there's just enough there. >> it's like polio or something even worse. >> how about complications from blindness and other things? >> it's ridiculous. absolutely not acceptable in the 21st century. >> okay. we're going to pivot from measles to the world of media. the fcc has voted to redefine broad band by raising the minimum download speeds. companies like netflix have been supportive of higher speeds. it means more potential for subscribers to watch its online content. we'll talk about the value of video content with a guy who knows about it. jeff bewkes the chairman and ceo of time warner. also fred is with us. you are a board member. thank you for being here. >> a time warner board member. >> are you the head of the comp committee? >> i'm on the comp committee. >> so you have to be nice. that's how this works. >> that's why i'm here. >> there's a lot of deep mutual respect.
>> let's talk here. recently dish announced this sling tv project which effectively begins the unbundling process to some degree. you're part of pit. it's not completely unbundled. $20 basic project. cnn is a piece of it. but espn is now getting unbundled for the first time. and you're trying to go over the top with hbo. when are we going to hear about exactly when that -- >> this year. >> this year. how do you think it changes the economics long-term? does it mean that content is going to be worth more or is it more like music? >> content's getting worth more all the time. there's more people watching it. they're watching it longer. and if you think about your own viewing habits you're probably following your favorite show even more closely than you ever did because you can watch it whenever you want. you can watch two or three episodes at a time. and you can do it not just on your tv if you don't want that big high definition experience. you can be watching it on a smaller screen on the subway or something like that.
so what's happening all over the world is that tv content's getting better and people are getting more support about it. there are other ways to find if you want to get advertising, that's one way to do it. if you want to pay for the channel you like you can do it that way. so it's giving you more choice. it's giving you more quality. it's kind of an explosion of activity. and now we've got the internet which is a way to deliver tv even in more optional environments and manners. so basically it's good in a worldwide matter. >> i can see why it works for the next couple years in people who control the bundle or people who are unbundling. but at some point does the economics of the whole thing break down? >> no. it's getting better. i would challenge this bundling idea -- i don't know what the viewers are thinking when they are about a bundle. is it laundry? what is it? it's basically you think about
your television dial you have hundreds of channels and choice. and that's very valuable. because if your house, different people want different things. everyone has their favorite ten or so channels that they watch. it's just that your ten are different than your wife's ten. and your kids' are different yet again. so i don't think we're really looking at this quote, unquote, unbundling. i think we're talking about more choice. so if you want the most choice or the most convenience, you go watch in your house and keep watching as you leave the house. you're going to want as many channels as you can. >> i still don't have enough. i got like 1200 and i want -- and if i had to pay for each one individually, i think my bill would be higher wouldn't it? >> this has been a good deal. you're getting more channels and the price of it really has not gone up. if you think about what you used to pay for your long distance plus your television and then broadband came you're using more. you're getting a higher quality service.
and your average payment for the minutes you're using is probably flat or going down. >> i wanted to ask you about the merger mania that's been going on in this business. we have the comcast time warner cable merger out there. and the at&t/directv. it feels over the past couple months there's been shifting winds in terms of how people think or whether they think those deals are going through and when. where are you on that? >> well we're not in those deals. >> i know. where's your head in terms of whether those deals get approved and when they may get approved and what it means to you ultimate will i? >> okay. i think -- excuse me -- what you see because it's taking a little while is that i think a proper concern of how do we get a broadband infrastructure in the united states that's a 21st century infrastructure. you've got all these people you want more device use, mobile use. all of this provides broadband
upgrade. and so we want to make sure that there is competition in the world of broadband providers. sop you don't want to be down to just one or practically one or two. so you need to have effective competition. but you also need for the health of these companies whether it's verizon, comcast, directv, they need to be able to be able to get a return on the investment that's to create the broadband infrastructure. so i think policy has to foster competition and it has to preserve returns because if you take video use in the united states on broadband every night, right now we're using up about half the broadband capacity in just a couple of video channels like youtube and netflix. and if we're going to see -- which we can obviously see -- all these other television channels going on broadband, if we don't have more capacity if those provider companies don't
invest billions of dollars more in a much more vibrant broadband system we won't have what we need. >> we've spoken to randall stevenson about this. he says at&t is putting a freeze until they figure which direction the fcc is headed. he thinks you're going to be looking at years of court decisions on top of this that these things will be tried out in the courts will take years of time. are you doing a similar sort of watch and see what happens and wait before you spend money before you get to that? >> no. because we're not in the did -- >> in the actual cable business. >> so what we've been doing for many years, the whole last five years as many other sectors have been a little flatter. in the media business making tv shows and movies. we've been just increasing the amount that we're investing, the increase of the number of shows we're making the quality of what's going sboon into all of our shows is going up. i think that's true not just of time warner but a number of
others. >> but then hbo over the top too. >> hbo is a great example. because they've got more new shows in the pipeline than they've ever had before. and the biggest hit they've ever had. "game of thrones" is a bigger hit. it's on the air now. it's coming back in april for those that want to set their dvr. >> i want to play you something and get your reaction. earlier this month we had mel karmazin on the show. here's what he had to say about a deal that he thought should take place between time warner and cbs. >> the deal that should get done that should be absolutely would be the best deal that i would even invest money in would be the combination of time warner and cbs. okay? that is a match that makes such great logic. >> how's mel karmazin's logic? >> well, it sounds like he already has invested money. i think he probably has kept a bit of his cbs stock.
>> he's waiting for you. >> i appreciate that a lot of people like to talk about these megadeals. that's not really how you make money in the media business if you look at the history of it. there probably have been more misses than hits when giant combinations like that have been tried. we never talk about any particular merger because then you'd ask me about five more and if i didn't say exactly the same thing about each one, you'd wonder. that's not how we're growing time warner. >> you've done a spectacular job. you look at the stock and you are now back above. the question though becomes this, though about sort of the larger question for time warner. have you made the company more powerful or more vulnerable as a result of getting rid of the cable piece of the business and getting rid of the print piece of the business? >> well we think that the verdict is clear because the
market for all of us watching this network, we know that the market is always right. and what the market looks and says is that the value of all these companies independently in their stock is more valuable than how they would have been and how they were when they were back together. that's true because the gains in time warner earnings have been more than any other media company in the last five years. same thing is true of our cable company. the magazine company is now the biggest independent. magazine company is doing very well because that industry is a slower growth industry than tv. it's now one of the great performers in that business where if you put it next to a television company given the strength of tv trends any magazine company would be the slowest growth part of a tv company. so i think it's very clear that we're stronger in our current more independent silos. but the real thing that time warner's got is focus, tv
production, networks movies. and yet we are the biggest in every one of those categories. it's not as though we need to add something in order to perform the way we have. >> jeff the super bowl is coming up. i don't remember the last time we were all talking about commercials. i don't watch commercials anymore. in fact, i try to watch as much nbc as possible but i might not watch that much broadcast television anymore. so this is a unique moment when i'm going to watch a super bowl and i'm going to watch the ads. but other than that i could go 364 days without seeing a commercial or a network. how's everybody going to get paid if it's not from commercials? >> well, you know first of all i think what you're saying when you watch the super bowl commercials is you like to watch a good ad. right? >> yeah, the ones i'll skip if i have a choice.
>> you're going to transition between the old media where there are all these ads during the breaks that weren't aimed at you. and in the new media, it knows what you're watching and it has an ad that you're interested in. so when you target you get better data you can have effective advertising. and we're just in the middle of a transition from one way where a lot of it was wasted that old saying. you know i don't know where half my ad dollars were wasted. that's what we're basically in the process of fixing. it's going to be better for the advertiser and viewer. >> be as much money when it's said and done. >> you're going to need to schedule your kitchen breaks because the ads will be so good you won't be able to leave the set. >> i have a question then. in pharmaceuticals the big differentiator is rnd and i think in your area it's content. how does one maintain that
vibrancy in content even as you get bigger and bigger how do you get the content to be different than the other guys? >> well that's been happening is the biggest talents, writers, directors, actors who used to go -- we all know this. they were all on the big screen and theater. and now really increasingly they're working more in tv because you can watch -- think of your favorite show. you can watch 20 hours of your favorite show your favorite characters, and that means you can make the show different. you can make it deeper. you cannot have it be so formulated where every eight minutes there's a crisis and then they go to commercial. that's how it's getting better. and the consequence is with all this mondayey coming in -- and it's happening globally so whatever you make for the united states is now of interest worldwide. you're just getting basically
more investment more quality, and therefore more excitement for the viewers. >> i want to ask you about yahoo! this week. because yahoo! is now spinning off alibaba. it's going to be on its own. you're on your own in a way. you've been part of aol or with ao aol, so you know. do you think that company has a future? there was a rumor they were going to buy cnn. yahoo!. >> i never heard that rumor. i should watch this show more. >> you said you watch this. >> i do watch the show. i should just watch it more. >> everybody should watch it more. >> so you're asking whether yahoo! has a future? >> what do you think of yahoo! on its own? >> you know i don't know enough to say exactly how strong it is or not. you know yahoo! aol, msn network are all sort of in a general portal business and they're all trying to evolve. they've got pretty big numbers in terms of who uses them and
the advertising. but i couldn't tell you where it's going from here. i know compared to that for them television is a better did -- >> bet. >> yeah. >> have you figured out the way to get paid for cable with millennials some day? where do they go? will they be back? >> that's a good question. there are more millennials using broadband tv and devices. and so it has always been true that when people in their 20s go out of school and they try to get a house, it takes them awhile to sign up for cable. that always was true. now i think it's getting a little different. because your question is right. whether they ever really want to pick up all these channels. but the thing that's really important is whether they get attached to this show to cnbc. and they don't have to have it in a cable channel in the future. they may be able to get it in a -- either a smaller bundle over broadband.
and so long as they're watching and they're paying for the subscription, i think you're going to have a good business. >> but that's the key for getting them to pay for subscriptions. they are used to getting everything for free finding it online somewhere. >> but you're younger than i am andrew. are you used to getting everything for free? >> i'm a cheapskate. i'd love to get things for free. but the carriage fee is key. so once you unbundle and the carriage fee becomes in question -- right? i would argue for cnn, advertising is what -- what percentage of the revenue is actually advertising on cnn relative to the carriage fee? >> much smaller on advertising. i think primetime advertising on cnn -- cnn by the way is up more than any other news channel this year. it's 10%. >> cnbc primetime is up more
than any. i don't want to quibble. i would never try to disagree with you. >> but the subscription fee, let's test what we're saying. plenty of people have signed up for a new thing called netflix. plenty more have signed up for hulu plus. those are subscription fees. those are very decent businesses. that's what happened with hbo 20, 30 years ago. hbo in the midst of all that just had the biggest year it's had in 20 years. you know so the freedom is really a way to say it. >> you bring up a good point. amazon's got its subscription services too. are they all going to exist or does somebody win out? >> you know let's look at what happened so far. so we got 100 million cable videos up. we've got a record number at hbo. it went up more last year than 20 years. and we added close to 40 million u.s. netflix subs at the same
time. none of that took away. we'll have to look at it on younger people but you're in the middle of a transition where clearly the programming is very good. i mean if i won't do it it's too self-serving to talk too much about adult swim one of our networks. we've got more 18 to 34s watching. >> and younger than that. he shouldn't be watching but he is. >> and when that channel is available on demand more effectively, you're going to see more people watching it. and you'll have people of that age that say, you know, i'll make a choice to sub vibescribe to that. >> i want to ask you a high minded question. this is stark contrast. i remember cnn -- everybody remembers cnn and the way they changed the world. it existed to bring us news as it was breaking. now if you were e ward r. murrow and you cynically looked at the
24-hour cable channels now, none of them do it without a point of view now, documentaries at night, it's almost not economically possible to do the public service aspect of -- >> i don't know. >> you think it's still possible to do it without a point of view? >> look at the last two weeks or three weeks with overseas. when something is happening, there's a huge habit not just in the states but all over the world and not just on television but on your mobile device of going to get your news from whether it's bbc or cnn and i think they're doing a better job than ever before at bringing you breaking news. and the question becomes when there isn't huge breaking news or even when there is and people are off watching a game show what is -- you know how much do you follow fewer ratings versus how much do you in our case we
numerous tienlmes of the week make the decision don't worry about the ratings, follow the news. because we want to serve our subscribers because most of our business, most of our money coming from our subscriber habit not from advertising. so it's a good thing that advertising is not the only determinant about what's on television. >> we're going to leave the conversation. don't be a stranger. we're neighbors now. >> i started work right here. >> thanks for being here this morning. >> thank you. >> thank you for forcing him to come here. >> no, he was really looking forward to it. >> he loved it. >> want to do it every day. >> "squawk box" regular jeff bewkes. when we come back this morning, data that could move the markets. stick around. "squawk box" will be right back. welcome back to showdown! jerry rice here with 8 year old andrew hunter debating who will win the big race between the tortoise and the hare. what do you think andrew? rabbits are faster. it's not a rabbit, it's a hare.
being a keen observer of the world has gotten you far but what if you could see more of what you wanted to know? with fidelity's new active trader pro investing platform, the information that's important to you is all in one place, so finding more insight is easier. it's your idea powered by active trader pro. another way fidelity gives you a more powerful investing experience. call our specialists today to get up and running.
is it? we know that. i know. earnings in just now from mastercard. profits of 69 cents a share beat estimates by 2 cents. revenue also above consensus. rival visa the dow component reported upbeat results after the bell yesterday. that's going to help the dow this morning. although we've got some work to do to turn the dow positive. coming up when we return we've got a key piece of economic data that could move the markets.
the government's first read on gdp in the fourth quarter. but take a look at u.s. equity futures right now. dow looks like it would open down 78 points. s&p 500 looking down about 15 points. but it all could change when we get the numbers. back in a moment. the problem is some of it's in this lab. some of it is in her head. some of it's in this new journal. and the rest of it is in your personal medical history. ibm watson can not only read this data, but understand it. it's trained by doctors. and it's always learning. it can help find hidden correlations and help your doctor recommend treatment options for you. there's a new way to work and it's made with ibm.
we are just seconds away from fourth quarter gdp. u.s. equity futures having weaker through the morning. you can see right now they're down. 85 down for the dow. rick santelli has the numbers. >> up .6% on employment cost index. but the big number gdp, a two handle. 2.6%. 2.6%. many were looking for between 2.8% and 3.2%. our last time around the block was 5%. let's look at the internals. assumptions strong at 4.3%. there's the silver lining. that's significantly more than the 4% we were looking for and a full percentage point bigger than the last. we were expecting close up to 1%. last look up 1.4%. unchanged.
that really is something big. and the pce quarter over quarter, up 1.1%. what as expected. you have to go back to the second quarter of 2013 to find a lower -- i'm sorry. of course other than the minus 2.1%. of course we're going to be looking at how the side is going to potentially save the day. it's a broad number. it takes into account things like transfers from the government so i don't know how much it is in the micro sense. but in a macro sense, we have to call this final quarter of 2014 a bit of a miss. it seems to underscore how we jump to inventory bill to inventory bill. here's the big news in interest
rates. we are now under that very significant 171 close from the 15th of january. so it makes it a trifecta. we now have all the key maturities below numbers. and the only jump to the sovereigns. back to you. >> thank you, rick. steve leisman is on the west coast this morning san francisco, where he's going to be interviewing san francisco fed president. good morning. >> yeah. the cci is not showing a whole lot of change in the year over year rate, andrew. but i think the story here is it does kind of contradict the negative number we had in december. the notion of waging falling. i didn't get the business spending and the inventory numbers. that strong consumer spending number that rick talked about seemed to be even stronger than
what was pretty much estimated. that plus 4% number. inventories could have gone either way. and one of the reasons why economists were a little nervous about this number prices having falling so they didn't now how inventories can be valued. we'll see if that gets adjusted over time. i'll look at the inventory. some of this is estimated. 2.6% would be the first -- i think it was six out of the last seven we've been above 3%. we had those two strong quarters. but really the devil is going to be many the details here, andrew. >> okay, steve. thank you. >> steve, what is the connection between the fed and john williams? i don't -- i don't -- is he -- is he a -- is he someone that -- i mean he has a big interest in
that? >> you know my interest in music. so it's just basically trying to bring the two together. >> is he involved with the new "star wars" there? >> i can't think of a good joke with fed policy and star wars. >> normally you could. it's early, isn't it? >> i could. it wouldn't be funny and it would be a reasonable attempt and i don't have it. but i will tell you you're one of eight guys that made that john williams joke. he is of course by the way the san francisco fed president and we will have an interview with him -- >> oh that john williams. >> i knew you knew him. >> you didn't make that clear. >> i thought maybe you knew him. but he's the san francisco -- he's a voter this year. so we're going to want to follow him. he's going to sit down for an interview on "street signs." >> steve, what is the first quarter gdp going to be? >> we don't have an estimate on that joe.
there's no tracking yet in terms of the cnbc rapid update. but i'm seeing again folks saying around 3% again. >> you take that in a minute, wouldn't you? >> i would take -- you know first of all this is above trend in terms of the ability to lower the unemployment rate. but still we were looking at 3%. all the data coming into it we have 3.2% in our rapid update. i would take 3% in a heart beat. >> that claims number was that going to be reversed? >> yeah i mean that was partially distorted by the mlk holiday. and the seasonal adjustments around it. but i will say a bunch of folks breathed a sigh of relief in the sense that heading up to that, people were saying don't pay a lot of attention to it. now it's coming below even despite the seasonals, there's a bit of a relief that we're not really having issues. i will say that torsten schlock,
he said that's equivalent to a 5.4% unemployment rate that we'll get next week. so that's heading down towards that level that the fed thinks is really the natural rate of unemployment. >> okay. all right. thank you, steve. >> guess what? john williams is doing the seventh "star wars." >> the fed guy? >> no. the other one. >> oh. okay. >> don't they just have to use the old -- they replay the same? >> no. they say he's signed on for the scores. he returned to score it. >> he's 82 years old. >> is he really? >> yeah. >> looks much better there. thanks, steve. said that like ten times. the dow is on pace for its worst month in a year despite the rally yesterday. we'll see what happens in the last trading day today. but we're starting off down
about 60 which came back a little. let's talk to senior portfolio manager. everybody said 8% to 10% for the year. not to say we won't do that bob, but january started out like we kind of paid some forward in the last quarter. did you feel that way? >> i certainly did. you might remember that happened last year when we had the hit last year proving that we borrowed some. i think we've done some of the same. 8% to 10% earnings is tall for this year. of course numbers have come down a little bit on the wake of the further decline in oil prices. their head winds, i think one of the confusing items right now, joe, is what's good for the economy is not necessarily good
for the stock market. we can argue the lower prices good for the economy. but at the moment, not particularly good for earnings. >> because of s&p oil related, we've got a lot of producers now which is a good thing for the country too. but we'll see that in comparisons year over year for their earnings. >> part of it is a timing issue. the hit to energy and related earnings from the decline in oil prices is nearly immediate. the benefit to everybody else consumers in particular is stretched out over time. so you have this immediate hit and the longer ramp to the upside. and that back and forth and that tradeoff i think is giving the market and a lot of investors confusing. it's not easy to figure out. >> you think that we do see the fed go up in june or september now? >> this year for sure. i saw a poll.
34% of investors think not until 2016. i think it's this year in part because they're starting at zero. it's not a low interest rate. it's a zero. we got to zero because of the emergency. the emergency in my adjustment is long past. they need to get rates where they belong relative to the economy which in my mind is low but not zero. >> bob, this is fred hassan. just a quick question. the oil prices have an effect on the inflation index. but the pattern on the core inflation, is that going up or is it flat? >> i think flattish. maybe down a touch. i think inflation will be another confusing subject this year. headline inflation thanks to oil will fall. core inflation as you mentioned, flattish. but wage rate inflation is going to start moving up. probably 2.5% this year. and so when we talk about inflation, we're going to have to be very clear what we're talking about. this is a very confusing period. it's sort of the transition in my view from the first half to
the second half of the business cycle. >> okay. bob doll thank you. we'll see you in the studio one of these days. and like we always say, may the fed be with you, bob. >> hear hear. thanks. >> you're welcome. okay. when we return social media in the big game. twitter and facebook and other sites will be flooded with everything from kickoff to commercials. the head of the nfl new york joins us to discuss that after the break. stamps.com is the best. i don't have to leave my desk and get up and go to the post office anymore. [ male announcer ] with stamps.com you can print real u.s. postage for all your letters and packages. i have exactly the amount of postage i need, the instant i need it. can you print only stamps? no... first class. priority mail. certified.
international. and the mail man picks it up. i don't leave the shop anymore. [ male announcer ] get a 4 week trial plus $100 in extras including postage and a digital scale. go to stamps.com/tv and never go to the post office again. do y ou like to travel? i'm all about "free" travel babe. that's what i do. [ female announcer ] fortunately, there's an easier way, with creditcards.com. compare hundreds of cards from every major bank and find the one that's right for you. creditcards.com. it's simple.
a few days until the super bowl and history is already being made. odell beckham jr. setting a guinness book world record for the most one-handed catches in a minute. he completed 33 with the help from drew brees. the espn televised event was a recreation of a visa commercial that digitally imposed three quarterbacks throwing to larry fitzgerald. this time it was for real. he actually did it. >> that's awesome. >> it is. >> thptink about when you let him use both hands. and you know what? isn't it weird i went to one game this year and i saw the catch. i was at the game and saw the o'delldell beckham catch. i feel like forrest gump. i'm there for sosantelli's rant. i'm there for so many things.
>> you're part of history. before sunday's kickoff much of the action takes place in the sports books. that's where hundreds of prop bets surrounding the super bowl are taking place. dave briggs is very lucky. he's already there and has that story for us from phoenix. >> guys an estimated $115 million expected to be wagered on super bowl xlix with the patriots a slight favorite and 73% of the action so far going on new england says sportsbooks,.com. the real fun starts with the more than 300 prop bets on the big game. before it starts you can bet on if marshawn lynch will be fined. odds say yes he will. color and style of hoodie bill belichick will wear. they say he'll ware a agree cutoff version. how many times will tom brady's supermodel wife been shown. the over/under is 1.5. sorry, guys. but the over/under on how much
times the deflategate scandal will be mentioned is three. who color of gatorade bath will soak the winning coach? orange the favorite. and afterwards who's headed for disneyland? brady to be the mvp followed by wilson and lynch. >> all right. we're just two days away from super bowl xlix. social media is already on fire. tweets involving the super bowl for this month 52% from last year. in the latest deal with youtube with the executive for media for the nfl. man, oh, man, brian. what a year right? but maybe a game that everybody hoped we'd have at the begin og they have year and now we're going to have it. >> yeah. it's been a good year so far. i don't know who you're cheering
for, but i think we've got a good one. >> i can't pick. i really can't. people want me to say you can't go for the patriots now because of this. and -- but look at how both of them got here. look what russell had to do to get here. look what brady had to do against the ravens to get here to set this whole thing up. i don't know. it's like it was in the stars or something. >> well, i think that's one of the attractive things about this game and the super bowl in general is the story lines are just so good and how these guys got here and the things they did to get here are good. but as i say, i don't cheer for teams. i cheer for tv ratings. so we'll have a winner. >> the whole football, this whole thing, you know 45-7. i don't know what happened. i don't know how it happened. i've seen people say baseball has really got the upper hand now. then i think about if it was a pound below but you look at -- who's the home run leader now? who's the all-time home run leader? can you answer that question for
me right now, brian? >> i don't think i can. >> i don't know who it is. i don't know who it is. because i don't know whether to say barry bonds. i don't know what to -- i mean are you kidding me? so these problems rise to the same level that other sports have been faced with in the past? >> look i think people love to talk about things they feel passionate about. and people feel passionate about the nfl. they feel passionate about their team. they feel passionate about this week. and i think people find a lot of things to talk about. so this is just one of them. >> in other years, it's a two-week period some of us are ready to not look at the sports page because they're so hungry for stories and sports writers have to crank it out every day. at least there's been someone to pine on and they certainly have. >> i think that's right. but i also think if you think where a lot of the fans are spending their time and you talked about it on social and twitter specifically but in social in general. there's a lot of talk about the game. there's a lot of talk about the stories as you mentioned of how the seahawks got here.
and i think, you know maybe what the fans talk about and what the media talk about sometimes are two different things. but that's okay. we stay focused on the game and we stay focused on really why people are tuning in. >> that's good. so overall nfl even with some of the problems -- i still -- you know, i worry about head injury and parents worry about their kids playing the game. you've got a lot of daunting challenges still. and then people point to roger goodell and what he makes and his relationship with bob kraft. is all this going to fade? >> look i can't predict the news cycle. i think we spend most of our time really thinking about making the game better making the game safer, and really bringing this content to fans who love it. we don't spend a ton of time worrying about what people might write or what they'll talk about. but i think -- >> they're going to write it. >> yeah. but we understand our position
in the sports landscape and we understand the responsibility that comes with it. and i think you've heard the commissioner say when these are issues we are going to lead on them and we are going to do our best. on head injuries rerecognized there's concerned out there but we also saw this is a sports problem in general. in keeping all people who play sports safe kids or otherwise, is a responsibility we all have. we'll continue to work hard at that. >> will we ever have a wednesday night football where the london -- i don't know what would they be? london bangers and mash play the mexico city -- i don't know -- will we ever have anything like that? will it be every night some day and will it be global? >> no. well, it certainly could be global. and we work very hard to make the game global. but you will not see wednesday night football. you will not see it every night of the week. the reality is is you can only
really play football once a week. and there are natural windows that we will play these games in. so you will not see football every night. we like the windows we have. >> okay. yeah, it'shave. >> yeah it's -- you know when i think about football is it -- it's a jewel and not everyone feels that way sometimes. but nothing's going to aggregate eyes like sunday. when people say, well the college game, you know, it was big but only got 35 million viewers. wow, that shows you how powerful it is. and it's going to be a great game. hope is it a great game. i don't see how it can't be with these two. >> look, i think it will be close. we had 111 million viewers last year, high-rated and most huge super bowl we had. the game wasn't as competitive as we would have liked it to be. hopefully we'll do better than that this year. it's interesting, you had jeff bewkes talking about content and changes in the media landscape.
i think one thing came through, i think jeff would probably agree, is that people will find content and they are attracted to the best content out there. i think sports in general, are one of the only things left if not the only things left that can aggregate these types of audiences and i think we'll see that sunday. >> brian, thanks. we look forward to it. you will too. it's on a great network, too, with the two best guys to broadcast it al michaels and cris collinsworth and the rest of the team. coverage 12:00 noon eastern sunday on nbc. >> when we come back jim cramer from the new york stock exchange, we'll talk about the week that was and what he's watching at the open take a look at futures at this hour because they are in the red. dow look likes it opened down 105. 102 points at this point. we'll come back in a moment. financial noise financial noise
welcome back. chevron beating the street. the company cutting 2015 capital budget by 13% as it deals with plunging oil prices. down to the new york stock exchange. jim cramer joins us now. hoping to ask you. >> google and amazon after the two stocks reported yesterday. >> google used the term discipline four times in the conference call. people have been feeling like
they've been spending like a drunken sailor. this is a an 18% revenue grower selling 17 times earnings. i want to own it. amazon amazeing. i didn't expect this quarter would show profitability. also once again, starting to get some real discipline. talking about invest, not spending. used the word spending over and over last quarter. not anymore. two companies i think they're chasing, tired of their stocks doing nothing, except going down and making astand here. it's very important. charitable trust owns google. wish we had more. >> amazon proved they could do it with the results, jim. i wonder if this is a standard they'll keep coming up to or is it we can do it when we want to or keep investing and this is what happens. >> right. what i call episodic profitable situation. they just -- they and raise it they can lower it. they can break out amazon
services. this is a conference call we've heard you and we know that you just don't want us to act like a private company. that's the same thing with google. both companies were all right, we know we screwed up we're not going to do it anymore, we do care about profitability. that was the first time. i mean google literally, one point said we care about profitability. what were you doing before that? talked about shelving google glass and monetization -- the super bowl commercials, watching them on youtube over and over already -- a breakout quarter for both. google obscure, so many one-time items, it's impossible. amazon, the stock's going to be up big. when the stock's up 40 probably goes up 70. >> see you in a few minutes? when we return shake shack to begin trading. danny meyer ahead in a little bit.
the lightest or nothing. the smartest or nothing. the quietest or nothing. the sleekest... ...sexiest ...baddest ...safest, ...tightest, ...quickest... ...harshest... ...or nothing. at mercedes-benz, we do things one way or we don't do them at all. introducing the all-new c-class. see your authorized mercedes-benz dealer for exceptional offers through mercedes-benz financial services. what can your fidelity greenline do for you? just take a closer look.
it works how you want to work. with a fidelity investment professional... or managing your investments on your own. helping you find new ways to plan for retirement. and save on taxes where you can. so you can invest in the life that you want today. tap into the full power of your fidelity greenline. call or come in today for a free one-on-one review. time for one quick thought from our guest host this morning, fred who has been here all morning. what are you thinking? >> andrew we can call this a life zins ofscience of century or the century of the empowered
consumer. now they can learn about health care from the web, they can take greater interest in their own health, be more focused on managing issues better. they can be better educated because they go to the doctor's office. this is the century of the empowered consumer. >> fred thank you so much for spending the morning with us. really really appreciate it. >> time for "squawk on the street." ♪ fries with that shake fries with that shake♪ >> a new york city hot dog cart. today on wall street. shake shack public at big board. talk to founder danny meyer and ceo randy garutti late art post 9. welcome to "squawk on the street." i'm carl quintanilla with jim cramer david faber at new york stock exchange. futures lower on the miss in fourth quarter gdp. earnings to get through. oil below $45. and the